H. K. Erichsen

发表

Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety

N. Mirza, G. Munro, H. K. Erichsen, 2007, Neuropharmacology.

Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain

Xiao-jun Xu, J. Hao, G. Blackburn-Munro, 2005, Pain.

The combined predictive capacity of rat models of algogen-induced and neuropathic hypersensitivity to clinically used analgesics varies with nociceptive endpoint and consideration of locomotor function

G. Munro, M. Sheykhzade, H. K. Erichsen, 2012, Pharmacology Biochemistry and Behavior.

PII: S0304-3959(02)00039-8

G. Blackburn-Munro, H. K. Erichsen, 2002 .

NS383 Selectively Inhibits Acid‐Sensing Ion Channels Containing 1a and 3 Subunits to Reverse Inflammatory and Neuropathic Hyperalgesia in Rats

T. Dyhring, G. Munro, P. Ahring, 2016, CNS neuroscience & therapeutics.

Pharmacological characterisation of the spared nerve injury model of neuropathic pain

G. Blackburn-Munro, H. K. Erichsen, 2002, Pain.

A comparison of the anti-nociceptive effects of voltage-activated Na+ channel blockers in the formalin test.

G. Blackburn-Munro, H. K. Erichsen, Nete Ibsen, 2002, European journal of pharmacology.

Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain

G. Blackburn-Munro, H. K. Erichsen, S. F. Bomholt, 2004, Neuropharmacology.

A comparison of the antinociceptive effects of voltage-activated Na+ channel blockers in two rat models of neuropathic pain.

Xiao-jun Xu, J. Hao, G. Blackburn-Munro, 2003, European journal of pharmacology.

The novel compound (±)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined μ-opioid receptor agonist and monoamine reuptake inhibitor tramadol

E. Nielsen, D. Peters, G. Munro, 2008, Neuropharmacology.

Characterization of a novel high-potency positive modulator of K(v)7 channels.

Palle Christophersen, D. Strøbæk, C. Hougaard, 2013, European journal of pharmacology.

Antiepileptics and the treatment of neuropathic pain: evidence from animal models.

G. Blackburn-Munro, H. K. Erichsen, Erichsen Hk, 2005, Current pharmaceutical design.

A question of balance – Positive versus negative allosteric modulation of GABAA receptor subtypes as a driver of analgesic efficacy in rat models of inflammatory and neuropathic pain

N. Mirza, G. Munro, M. Rae, 2011, Neuropharmacology.

NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a Unique Subtype-Selective GABAA Receptor Positive Allosteric Modulator: In Vitro Actions, Pharmacokinetic Properties and in Vivo Anxiolytic Efficacy

P. Ahring, H. K. Erichsen, C. Mathiasen, 2008, Journal of Pharmacology and Experimental Therapeutics.

Comparison of the Novel Subtype-Selective GABAA Receptor-Positive Allosteric Modulator NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with Diazepam, Zolpidem, Bretazenil, and Gaboxadol in Rat Models of Inflammatory and Neuropathic Pain

E. Nielsen, J. Lopez-Garcia, N. Mirza, 2008, Journal of Pharmacology and Experimental Therapeutics.

Positive allosteric modulation of GABA-A receptors reduces capsaicin-induced primary and secondary hypersensitivity in rats

N. Mirza, G. Munro, H. K. Erichsen, 2012, Neuropharmacology.